Cargando…
Propofol increases morbidity and mortality in a rat model of sepsis
INTRODUCTION: Severe sepsis is associated with approximately 50% mortality and accounts for tremendous healthcare costs. Most patients require ventilatory support and propofol is commonly used to sedate mechanically ventilated patients. Volatile anesthetics have been shown to attenuate inflammation...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344774/ https://www.ncbi.nlm.nih.gov/pubmed/25887642 http://dx.doi.org/10.1186/s13054-015-0751-x |
_version_ | 1782359485409394688 |
---|---|
author | Schläpfer, Martin Piegeler, Tobias Dull, Randal O Schwartz, David E Mao, Mao Bonini, Marcelo G Z’Graggen, Birgit Roth Beck-Schimmer, Beatrice Minshall, Richard D |
author_facet | Schläpfer, Martin Piegeler, Tobias Dull, Randal O Schwartz, David E Mao, Mao Bonini, Marcelo G Z’Graggen, Birgit Roth Beck-Schimmer, Beatrice Minshall, Richard D |
author_sort | Schläpfer, Martin |
collection | PubMed |
description | INTRODUCTION: Severe sepsis is associated with approximately 50% mortality and accounts for tremendous healthcare costs. Most patients require ventilatory support and propofol is commonly used to sedate mechanically ventilated patients. Volatile anesthetics have been shown to attenuate inflammation in a variety of different settings. We therefore hypothesized that volatile anesthetic agents may offer beneficial immunomodulatory effects during the course of long-term intra-abdominal sepsis in rats under continuous sedation and ventilation for up to 24 hours. METHODS: Sham operation or cecal ligation and puncture (CLP) was performed in adult male Wistar rats followed by mechanical ventilation. Animals were sedated for 24 hours with propofol (7 to 20 mg/kg/h), sevoflurane, desflurane or isoflurane (0.7 minimal alveolar concentration each). RESULTS: Septic animals sedated with propofol showed a mean survival time of 12 hours, whereas >56% of all animals in the volatile groups survived 24 hours (P <0.001). After 18 hours, base excess in propofol + CLP animals (−20.6 ± 2.0) was lower than in the volatile groups (isoflurane + CLP: -11.7 ± 4.2, sevoflurane + CLP: -11.8 ± 3.5, desflurane + CLP -14.2 ± 3.7; all P <0.03). Plasma endotoxin levels reached 2-fold higher levels in propofol + CLP compared to isoflurane + CLP animals at 12 hours (P <0.001). Also blood levels of inflammatory mediators (tumor necrosis factor-α, interleukin-1β, interleukin-10, CXCL-2, interferon-γ and high mobility group protein-1) were accentuated in propofol + CLP rats compared to the isoflurane + CLP group at the same time point (P <0.04). CONCLUSIONS: This is the first study to assess prolonged effects of sepsis and long-term application of volatile sedatives compared to propofol on survival, cardiovascular, inflammatory and end organ parameters. Results indicate that volatile anesthetics dramatically improved survival and attenuate systemic inflammation as compared to propofol. The main mechanism responsible for adverse propofol effects could be an enhanced plasma endotoxin concentration, leading to profound hypotension, which was unresponsive to fluid resuscitation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-015-0751-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4344774 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43447742015-03-01 Propofol increases morbidity and mortality in a rat model of sepsis Schläpfer, Martin Piegeler, Tobias Dull, Randal O Schwartz, David E Mao, Mao Bonini, Marcelo G Z’Graggen, Birgit Roth Beck-Schimmer, Beatrice Minshall, Richard D Crit Care Research INTRODUCTION: Severe sepsis is associated with approximately 50% mortality and accounts for tremendous healthcare costs. Most patients require ventilatory support and propofol is commonly used to sedate mechanically ventilated patients. Volatile anesthetics have been shown to attenuate inflammation in a variety of different settings. We therefore hypothesized that volatile anesthetic agents may offer beneficial immunomodulatory effects during the course of long-term intra-abdominal sepsis in rats under continuous sedation and ventilation for up to 24 hours. METHODS: Sham operation or cecal ligation and puncture (CLP) was performed in adult male Wistar rats followed by mechanical ventilation. Animals were sedated for 24 hours with propofol (7 to 20 mg/kg/h), sevoflurane, desflurane or isoflurane (0.7 minimal alveolar concentration each). RESULTS: Septic animals sedated with propofol showed a mean survival time of 12 hours, whereas >56% of all animals in the volatile groups survived 24 hours (P <0.001). After 18 hours, base excess in propofol + CLP animals (−20.6 ± 2.0) was lower than in the volatile groups (isoflurane + CLP: -11.7 ± 4.2, sevoflurane + CLP: -11.8 ± 3.5, desflurane + CLP -14.2 ± 3.7; all P <0.03). Plasma endotoxin levels reached 2-fold higher levels in propofol + CLP compared to isoflurane + CLP animals at 12 hours (P <0.001). Also blood levels of inflammatory mediators (tumor necrosis factor-α, interleukin-1β, interleukin-10, CXCL-2, interferon-γ and high mobility group protein-1) were accentuated in propofol + CLP rats compared to the isoflurane + CLP group at the same time point (P <0.04). CONCLUSIONS: This is the first study to assess prolonged effects of sepsis and long-term application of volatile sedatives compared to propofol on survival, cardiovascular, inflammatory and end organ parameters. Results indicate that volatile anesthetics dramatically improved survival and attenuate systemic inflammation as compared to propofol. The main mechanism responsible for adverse propofol effects could be an enhanced plasma endotoxin concentration, leading to profound hypotension, which was unresponsive to fluid resuscitation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-015-0751-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-19 2015 /pmc/articles/PMC4344774/ /pubmed/25887642 http://dx.doi.org/10.1186/s13054-015-0751-x Text en © Schläpfer et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Schläpfer, Martin Piegeler, Tobias Dull, Randal O Schwartz, David E Mao, Mao Bonini, Marcelo G Z’Graggen, Birgit Roth Beck-Schimmer, Beatrice Minshall, Richard D Propofol increases morbidity and mortality in a rat model of sepsis |
title | Propofol increases morbidity and mortality in a rat model of sepsis |
title_full | Propofol increases morbidity and mortality in a rat model of sepsis |
title_fullStr | Propofol increases morbidity and mortality in a rat model of sepsis |
title_full_unstemmed | Propofol increases morbidity and mortality in a rat model of sepsis |
title_short | Propofol increases morbidity and mortality in a rat model of sepsis |
title_sort | propofol increases morbidity and mortality in a rat model of sepsis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344774/ https://www.ncbi.nlm.nih.gov/pubmed/25887642 http://dx.doi.org/10.1186/s13054-015-0751-x |
work_keys_str_mv | AT schlapfermartin propofolincreasesmorbidityandmortalityinaratmodelofsepsis AT piegelertobias propofolincreasesmorbidityandmortalityinaratmodelofsepsis AT dullrandalo propofolincreasesmorbidityandmortalityinaratmodelofsepsis AT schwartzdavide propofolincreasesmorbidityandmortalityinaratmodelofsepsis AT maomao propofolincreasesmorbidityandmortalityinaratmodelofsepsis AT boninimarcelog propofolincreasesmorbidityandmortalityinaratmodelofsepsis AT zgraggenbirgitroth propofolincreasesmorbidityandmortalityinaratmodelofsepsis AT beckschimmerbeatrice propofolincreasesmorbidityandmortalityinaratmodelofsepsis AT minshallrichardd propofolincreasesmorbidityandmortalityinaratmodelofsepsis |